Stock listing
Aptevo Therapeutics Inc.
Selected listing: APVO · NASDAQ · USD · US
Aptevo Therapeutics Inc. (NASDAQ:APVO), Health Technology. Latest release Sep 3, 2026: Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet…
- Ticker
- NASDAQ:APVO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a public company traded under the ticker APVO in the American market. Aptevo focuses on developing innovative therapeutics for various medical conditions.
Latest news from Aptevo Therapeutics Inc.
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
September 3, 2026
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
August 14, 2026
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
August 13, 2026
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
August 12, 2026
As Big Pharma Bets On Radiopharmaceuticals, Aptevo And Niowave Join Forces To Advance Novel Targeted Cancer Therapeutics In The $17B+ Oncology Category
June 8, 2026
Research Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. company profile
View the public company page for Aptevo Therapeutics Inc. on 6ix.
Aptevo Therapeutics Inc. news
Read company news and market updates connected to Aptevo Therapeutics Inc..
Aptevo Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Aptevo Therapeutics Inc..
Alternate listings
APVO:BOATS
US · USD
Alternate listing for Aptevo Therapeutics Inc.; the primary context on this page is APVO:NASDAQ.
AP82:GETTEX
DE · EUR
Alternate listing for Aptevo Therapeutics Inc.; the primary context on this page is APVO:NASDAQ.
AP82:FWB
DE · EUR
Alternate listing for Aptevo Therapeutics Inc.; the primary context on this page is APVO:NASDAQ.
AP82:MUN
DE · EUR
Alternate listing for Aptevo Therapeutics Inc.; the primary context on this page is APVO:NASDAQ.